Clinical Trial Update: Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

View source ↗

Summary

A completed clinical trial evaluating Enbrel (etanercept) as a biological treatment for moderate to severe plaque psoriasis, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Plaque Psoriasis | Status: COMPLETED | Results posted: 2021-11-01